Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combination chemotherapy of serine protease inhibitor nafamostat mesilate with oxaliplatin targeting NF-κB activation for pancreatic cancer

Published:2013-06 Issue:1 Volume:333 Page:89-95
ISSN:0304-3835
Container-title:Cancer Letters
language:en
Short-container-title:Cancer Letters

Author:

Gocho Takeshi,Uwagawa Tadashi,Furukawa Kenei,Haruki Koichiro,Fujiwara Yuki,Iwase Ryota,Misawa Takeyuki,Ohashi Toya,Yanaga Katsuhiko

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference57 articles.

1. American Cancer Society, Global Cancer Facts & Figures 2nd Edition, Atlanta, Ga, USA. (accessed 01.12.12).

2. American Cancer Society, Cancer Facts & figures 2012, Atlanta, Ga, USA. (accessed 12.10.12).

3. Resected adenocarcinoma of the pancreas – 616 patients: results, outcomes, and prognostic indications;Sohn;J. Gastrointest. Surg.,2000

4. Pancreatic cancer;Yeo;Curr. Probl. Cancer,2002

5. The National Cancer Date Base report on pancreatic cancer;Niederhuber;Cancer,1995

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecule inhibitors targeting m6A regulators;Journal of Hematology & Oncology;2024-05-06

2. TCT‐Mediated Process for the Preparation of Nafamostat Mesylate and Camostat Mesylate;ChemistrySelect;2023-05-10

3. Nafamostat Mesylate in Combination with the Mouse Amino-Terminal Fragment of Urokinase–Human Serum Albumin Improves the Treatment Outcome of Triple-Negative Breast Cancer Therapy;Molecular Pharmaceutics;2022-12-04

4. Global Effect of COVID-19 Pandemic on Cancer Patients and its Treatment: A Systematic Review;Clinical Complementary Medicine and Pharmacology;2022-12

5. The immuno-oncological challenge of COVID-19;Nature Cancer;2020-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3